Ramos, E.; López-Muñoz, F.; Gil-Martín, E.; Egea, J.; Álvarez-Merz, I.; Painuli, S.; Semwal, P.; Martins, N.; Hernández-Guijo, J.M.; Romero, A.
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy. Antioxidants 2021, 10, 1152.
https://doi.org/10.3390/antiox10071152
AMA Style
Ramos E, López-Muñoz F, Gil-Martín E, Egea J, Álvarez-Merz I, Painuli S, Semwal P, Martins N, Hernández-Guijo JM, Romero A.
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy. Antioxidants. 2021; 10(7):1152.
https://doi.org/10.3390/antiox10071152
Chicago/Turabian Style
Ramos, Eva, Francisco López-Muñoz, Emilio Gil-Martín, Javier Egea, Iris Álvarez-Merz, Sakshi Painuli, Prabhakar Semwal, Natália Martins, Jesús M. Hernández-Guijo, and Alejandro Romero.
2021. "The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy" Antioxidants 10, no. 7: 1152.
https://doi.org/10.3390/antiox10071152
APA Style
Ramos, E., López-Muñoz, F., Gil-Martín, E., Egea, J., Álvarez-Merz, I., Painuli, S., Semwal, P., Martins, N., Hernández-Guijo, J. M., & Romero, A.
(2021). The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy. Antioxidants, 10(7), 1152.
https://doi.org/10.3390/antiox10071152